You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

mass. movers

Repligen’s revenue slides 18.2 percent

For fiscal 2014, Repligen sees $54 million to $57 million in revenue and net income of $7 million to $9 million.

New York Times/File 2006

For fiscal 2014, Repligen sees $54 million to $57 million in revenue and net income of $7 million to $9 million.

Continue reading below

Waltham-based Repligen Corp., which produces products used in the manufacturing of biological drugs, reported quarterly revenue of $15.4 million, an 18.2 percent decrease from the year-earlier quarter, as adjusted earnings per share fell to 10 cents from 30 cents. Wall Street estimates had called for $15.9 million in revenue and 14 cents in per-share earnings. If there was a bright spot, Motley Fool reported, it was that bioprocessing revenue jumped nearly 7 percent to $10.4 million.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com